Vimian Group AB (publ) (VIMGF)
OTCMKTS · Delayed Price · Currency is USD
3.010
-1.290 (-30.00%)
At close: Sep 10, 2025
Vimian Group AB Market Cap
Vimian Group AB has a market cap or net worth of $1.65 billion as of December 17, 2025. Its market cap has decreased by -22.78% in one year.
Market Cap
1.65B
Enterprise Value
1.92B
Revenue
493.96M
Ranking
n/a
PE Ratio
44.60
Stock Price
$3.01
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 1.65B, a decrease of -54.78%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 1.65B | -12.56% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
| Jun 18, 2021 | 3.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 383.23M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |